Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children (Q24241491)

1

0 references

Adli Khalil

2

0 references

Khalid A Khalaiwi

3

0 references

Ruth A Milner

4

0 references

Mohammed A Al Othman

Cochrane Database of Systematic Reviews

6

0 references

publication date

21 January 2009

0 references

published in

0 references

cites work

A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

Selecting and appraising studies for a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Publication bias in meta-analysis: its causes and consequences

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Treatment of acute group A beta-hemolytic streptococcal tonsillitis in children with a 5-day course of josamycin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

The global burden of group A streptococcal diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Rheumatic fever--is it still a problem?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021

Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004872.PUB2

7 January 2021